Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
May 13, 2022 |
referred to economic development |
Assembly Bill A10369
2021-2022 Legislative Session
Sponsored By
BROWN K
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
David McDonough
Joe DeStefano
Joe Angelino
2021-A10369 (ACTIVE) - Details
- Current Committee:
- Assembly Economic Development
- Law Section:
- Alcoholic Beverage Control Law
- Laws Affected:
- Amd §106, ABC L; amd §77, Cannabis L
- Versions Introduced in 2023-2024 Legislative Session:
-
A5580
2021-A10369 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 10369 I N A S S E M B L Y May 13, 2022 ___________ Introduced by COMMITTEE ON RULES -- (at request of M. of A. K. Brown) -- read once and referred to the Committee on Economic Development AN ACT to amend the alcoholic beverage control law and the cannabis law, in relation to requiring certain businesses in which alcohol or canna- bis is consumed to have opioid antagonists THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 106 of the alcoholic beverage control law is amended by adding a new subdivision 18 to read as follows: 18. ALL RETAIL LICENSEES FOR ON-PREMISES CONSUMPTION SHALL CONTAIN AN OPIOID ANTAGONIST TO BE ADMINISTERED TO PATRONS, STAFF OR INDIVIDUALS ON PREMISES OF SUCH ESTABLISHMENT. FOR THE PURPOSES OF THIS SUBDIVISION, "OPIOID ANTAGONIST" MEANS NALOXONE, NARCAN OR ANY OTHER MEDICATION APPROVED BY THE DEPARTMENT OF HEALTH AND THE FEDERAL FOOD AND DRUG ADMINISTRATION THAT, WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL EFFECTS OF AN OPIOID IN THE HUMAN BODY. § 2. Section 77 of the cannabis law is amended by adding a new subdi- vision 15 to read as follows: 15. EACH ADULT-USE ON-SITE CONSUMPTION LICENSEE SHALL CONTAIN AN OPIOID ANTAGONIST TO BE ADMINISTERED TO PATRONS, STAFF OR INDIVIDUALS ON PREMISES OF SUCH ESTABLISHMENT. FOR THE PURPOSES OF THIS SUBDIVISION, "OPIOID ANTAGONIST" MEANS NALOXONE, NARCAN OR ANY OTHER MEDICATION APPROVED BY THE DEPARTMENT OF HEALTH AND THE FEDERAL FOOD AND DRUG ADMINISTRATION THAT, WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL EFFECTS OF AN OPIOID IN THE HUMAN BODY. § 3. This act shall take effect on the ninetieth day after it shall have become a law. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD15557-01-2
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.